Impact factor arthritis res ther

Author: xzyj

August undefined, 2024

WitrynaArchive of "Arthritis Research & Therapy". - PMC. Journal List. Arthritis Res Ther. The archive for this journal includes: Arthritis Res Ther: Vols. 5 to 25; 2003 to 2024. … Witryna16 paź 2024 · Background: Psychosocial health is a key driver of quality of life (QoL) in axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), but it is often overlooked in clinical practice. We aimed to analyze this aspect of QoL by using the Assessment of SpA International Society–Health Index (ASAS HI) in both SpA phenotypes. …

Impact of obesity on the response to tumor necrosis factor …

WitrynaArthritis Research & Therapy Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1478-6354. ... Enter journal title, issn or abbr in this box to search. Arthritis Research & Therapy. Journal Abbreviation: ARTHRITIS RES THER ... 1478-6354. Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 update) 5 ... WitrynaLiczba wierszy: 13 · Arthritis Research & Therapy Impact Factor, IF, number of article, … iowa rest areas with rv dump stations

Rheumatoid arthritis and risk of cardiovascular disease - PMC

Witryna5 mar 2014 · Arthritis Res Ther. 2014 Mar 5;16(2):R61. doi: 10.1186/ar4498. ... association between pack-years of cigarette smoking and rheumatoid arthritis were included in a dose-response random-effects meta-regression analysis. Results: ... Risk Factors Smoking / adverse effects* ... Witryna23 mar 2024 · Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies … Witryna29 sie 2024 · Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in vitro effects of GM-CSF on the … iowa rest areas map

Treatment persistence of biologics among patients with psoriatic arthritis

JCM Free Full-Text Non-Physical Disease Facets in …

Witryna10 lut 2024 · Etanercept is an antagonist of tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used widely in severe forms of rheumatoid arthritis and psoriasis. Etanercept has been linked to rare instances of acute, clinically apparent liver injury. WitrynaArthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, publishes original … iowa results 2020Witryna29 sty 2024 · Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an important factor in individualized patient treatment planning and healthcare policy and guideline development. To estimate the persistence of biologic agents prescribed to PsA patients in a real-life setting as well as factors associated with improved biologic drug … iowa restoration of firearms rights

"WitrynaThe Journal of Orthopaedic Research®, a publication of the Orthopaedic Research Society (ORS), is the forum for the rapid publication of high quality reports of new information on the full spectrum of orthopaedic research, including life sciences, engineering, translational, and clinical studies. Announcement of JOR Special Issue - … " - Impact factor arthritis res ther

Impact factor arthritis res ther

JCM Free Full-Text Non-Physical Disease Facets in …

Witryna19 lip 2024 · Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. ... the impact of a high BMI on the response to tumor necrosis factor inhibitors (TNFi) has only been formally demonstrated for infliximab in two retrospective ... Arthritis Res Ther. 2016; 18:71. doi: 10.1186/s13075-016-0969-2. … WitrynaArthritis Care & Research. Journal Abbreviation: ARTHRIT CARE RES. Journal ISSN: 2151-464X. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) …

Did you know?

WitrynaThe journal was established in 1999 as Arthritis Research, obtaining its current title in. The journal's print version ceased in 2010 with volume 12, number 6, and the journal … Witryna27 mar 2024 · Arthritis Res Ther. 2008; 10 (3) R59. ... The effects of tumour necrosis factor inhibitors, methotrexate, nonsteroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74 (3):480–489.

Witryna27 maj 2024 · The impact score (IS) 2024 of Arthritis Research and Therapy is 4.93, which is computed in 2024 as per its definition.Arthritis Research and Therapy IS is … Witryna21 gru 2024 · The factors found to be significantly correlated with ... general health version in patients with rheumatoid arthritis Arthritis Res Ther 2010 125 R177 20860837 ... Strand V Jones TV Li W Koenig AS Kotak S The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic …

Witryna13 kwi 2024 · Ozoralizumab (OZR), a tumor necrosis factor alpha (TNFα) inhibitor, is a NANOBODY® compound that binds to TNFα and human serum albumin. The main objective of this study was to analyze the pharmacokinetics (PK) of the drug and its correlation with clinical efficacy in patients with rheumatoid arthritis (RA). Efficacy … WitrynaThe journal was established in 1999 as Arthritis Research, obtaining its current title in. The journal's print version ceased in 2010 with volume 12, number 6, and the journal converted to an online only format. According to the Journal Citation Reports, the journal has a 2024 impact factor of 4.269. References

Witryna13 kwi 2024 · Rheumatoid arthritis (RA) is a chronic inflammatory joint disease affecting around 0.5 to 1.0% of the adult population [].Therapeutic drugs against RA include synthetic and biological disease-modifying anti-rheumatic drugs (DMARDs), and glucocorticoids [].Despite available treatment options, a significant proportion of …

WitrynaARTHRITIS RESEARCH & THERAPY. 出版年份：2003 年文章数：260 投稿命中率：50.0%. 出版周期：Bimonthly 自引率：4.5% 审稿周期：平均4.71月. 前往期刊查询. 期刊讨论中国SCI论文期刊主页投稿经验杂志官网投稿链接作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ... iowa resultsWitryna22 lut 2024 · Arthritis Res Ther. 2024 Feb 22;24(1):53. doi: 10.1186/s13075-022-02746-5. Authors ... (RA) treatment, it is necessary to understand each RA patient's … iowa restricted dealer licenseWitrynaISSN (Online) The ISSN (Online) of Arthritis Care and Research is 2151-4658 .An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic. Arthritis Care and Research Key Factor Analysis Arthritis Care and ResearchのISSN(Online)は 2151-4658 です。 ISSNは、 … iowa restaurant inspection searchWitryna25 sty 2013 · Arthritis Res Ther. 2013 Jan 25;15(1):R20. doi: 10.1186/ar4152. ... Using propidium iodide uptake and flow cytometry, we compared RTX-CDC with rheumatoid … iowa restraining order change formWitryna《arthritis research & therapy》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《arthritis res ther》" 杂志的可信度。学术期刊真正的价值在 … iowa results 2012Witryna22 gru 2024 · Background: To evaluate the effects of tumor necrosis factor inhibitors (TNFi), interleukin-6 receptor inhibitors (IL-6Ri), and Janus kinase inhibitors (JAKi) on … open dot and closed dot meaningWitryna18 wrz 2014 · Considering the dosage and potential adverse effects of bevacizumab, the local administration of bevacizumab is a more advantageous approach than systemic administration. ... Arthritis Res Ther. 2014 Sep 18;16(5):427. doi: 10.1186/s13075-014-0427-y. ... Bevacizumab did not increase the expression of genes for catabolic … open dot and closed dot math